Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan

AIMS/INTRODUCTION: Diabetic polyneuropathy is one of the most frequent diabetic complications, and impairs patients’ quality of life. We evaluated the efficacy and safety of ranirestat (40 mg/day) in patients with diabetic polyneuropathy. MATERIALS AND METHODS: This was a multicenter, placebo‐contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiguchi, Kenji, Kohara, Nobuo, Baba, Masayuki, Komori, Tetsuo, Naito, Yutaka, Imai, Tomihiro, Satoh, Jo, Yamaguchi, Yasuyuki, Hamatani, Tatsuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400176/
https://www.ncbi.nlm.nih.gov/pubmed/29975462
http://dx.doi.org/10.1111/jdi.12890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400176/
https://www.ncbi.nlm.nih.gov/pubmed/29975462
http://dx.doi.org/10.1111/jdi.12890

Ejemplares similares